PA
WX

Profund Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Profund Advisors’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-22,504
Closed -$972K – 1333
2015
Q3 		$972K Sell
22,504
-6,946
-24% -$293K 0.06% 293
2015
Q2 		$1.25M Buy
29,450
+4,165
+16% +$176K 0.05% 308
2015
Q1 		$981K Buy
25,285
+203
+0.8% +$7.82K 0.04% 502
2014
Q4 		$845K Sell
25,082
-8,934
-26% -$316K 0.03% 526
2014
Q3 		$1.19M Buy
34,016
+3,457
+11% +$118K 0.06% 332
2014
Q2 		$1M Sell
30,559
-769
-2% -$26.3K 0.04% 473
2014
Q1 		$1.16M Sell
31,328
-4,009
-11% -$147K 0.05% 397
2013
Q4 		$1.36M Buy
35,337
+23,187
+191% +$732K 0.06% 328
2013
Q3 		$333K Buy
+12,150
New +$288K 0.02% 1236

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Profund Advisors's WX Position: Q4 2015 in Review

Profund Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 22,504 shares — an estimated $972K sold.

Profund Advisors first reported a position in WX in Q3 2013 and held it in 9 quarters. The position peaked at $1.36M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Profund Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Profund Advisors sold 22,504 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $972K.
  • Profund Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 9 quarters.
  • Profund Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.36M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Profund Advisors's 13F filing for Q4 2015, filed 5 Feb 2016.